Inventor · disambiguated record
Jing Yang
Also filed as: YANG JING · YANG JING-XING
29 granted patents·22 pending applications·431 citations·filing 2002–2023
96Inventor score
Top patents by PatentIndex Score
51 records- 0198US8226611B2Anti-IL-6 antibodies, compositions, methods and usesCHEN YAN·Filed 2011·Granted Jul 24, 2012·64 cites·8 claims
- 0298US7560112B2Anti-il-6 antibodies, compositions, methods and usesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted Jul 14, 2009·84 cites·16 claims
- 0397US8623362B2Anti-IL-6 antibodiesCHEN YAN·Filed 2012·Granted Jan 7, 2014·44 cites·11 claims
- 0497US8067003B2Methods of treating conditions using anti-IL-6 antibodiesCHEN YAN·Filed 2010·Granted Nov 29, 2011·46 cites·12 claims
- 0597US7833755B2Anti-IL-6 antibody nucleic acid molecules and methodsCHEN YAN·Filed 2009·Granted Nov 16, 2010·50 cites·12 claims
- 0694USRE43672EAnti-IL-6 antibodies, compositions, methods and usesCHAN YAN·Filed 2011·Granted Sep 18, 2012·47 cites·16 claims
- 0793US11739294B2Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2020·Granted Aug 29, 2023·2 cites·21 claims
- 0893US8568998B2Methods of diagnosing, preventing and treating cancer metastasisMANI SENDURAI·Filed 2011·Granted Oct 29, 2013·65 cites·11 claims
- 0988US12410399B2Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2023·Granted Sep 9, 2025·0 cites·18 claims
- 1088US8013015B2Small molecule inhibitors of ghrelin O-acyltransferaseUNIV TEXAS·Filed 2009·Granted Sep 6, 2011·8 cites·24 claims
- 1186US9107897B2Methods for isolating mammalian retinal progenitor cellsKLASSEN HENRY·Filed 2012·Granted Aug 18, 2015·7 cites·8 claims
- 1285US9963675B2Compositions and methods for treating retinal diseasesKLASSEN HENRY·Filed 2016·Granted May 8, 2018·4 cites·16 claims
- 1384US7547767B2Growth arrest specific gene 6 peptides, antibodies, compositions, methods and usesCENTOCOR ORTHO BIOTECH INC·Filed 2006·Granted Jun 16, 2009·8 cites·5 claims
- 1482US11202827B2Dosage and administration of non-fucosylated anti-CD40 antibodiesSEAGEN INC·Filed 2017·Granted Dec 21, 2021·2 cites·170 claims
- 1581US12065488B2Anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 1681US2024075134A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2023·Application pending·0 cites
- 1780US2024075135A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2023·Application pending·0 cites
- 1879US2023201344A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2022·Application pending·0 cites
- 1978US2023201343A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 2078US2022265822A1Dosage and administration of non-fucosylated anti-cd40 antibodySEAGEN INC·Filed 2022·Application pending·0 cites
- 2177US2022249662A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 2274US11180549B2Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Nov 23, 2021·0 cites·12 claims
- 2373US10781422B1Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2020·Granted Sep 22, 2020·0 cites·17 claims
- 2472US10822585B2Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2020·Granted Nov 3, 2020·0 cites·40 claims
- 2572US10752882B2Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2018·Granted Aug 25, 2020·0 cites·8 claims
- 2667US9340613B2Anti-IL-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted May 17, 2016·0 cites·9 claims
- 2766US11898147B2CpG-oligodeoxynucleotide compounds in combination with immune modulators for cancer immunotherapyNATIONAL HEALTH RES INST·Filed 2021·Granted Feb 13, 2024·0 cites·3 claims
- 2865US2017253651A1Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 AntibodyJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 2964US9631016B2Pen-injector device containing anti-IL-6 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Apr 25, 2017·0 cites·13 claims
- 3063US2024115681A1Pharmaceutical composition comprising toll-like receptor agonist and stimulator of interferon genes agonist and use thereofNATIONAL HEALTH RES INST·Filed 2023·Application pending·0 cites
- 3160US11213584B2Dosage and administration of non-fucosylated anti-CD40 antibodiesSEAGEN INC·Filed 2015·Granted Jan 4, 2022·0 cites·46 claims
- 3259US2024279310A1Methods of dosing and treatment with a taci-fc fusion immunomodulatory proteinALPINE IMMUNE SCIENCES INC·Filed 2022·Application pending·0 cites
- 3358US10041041B2Compositions and methods for treating retinal diseasesUNIV CALIFORNIA·Filed 2015·Granted Aug 7, 2018·0 cites·10 claims
- 3457US12410398B2Methods of human retinal progenitor cell isolation and cultureUNIV CALIFORNIA·Filed 2019·Granted Sep 9, 2025·0 cites·19 claims
- 3557US8088590B2Use of FOXC2 in diagnosing, preventing and treating cancer metastasisMANI SENDURAI·Filed 2006·Granted Jan 3, 2012·0 cites·5 claims
- 3657US2024335427A1Small molecule inhibition of deubiquitinating enzyme josephin domain containing 1 (josd1) as a targeted therapy for leukemias with mutant janus kinase 2 (jak2)DANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 3756US2025041298A1Cdk4 inhibitor for the treatment of cancerPFIZER·Filed 2022·Application pending·0 cites
- 3856US2025041277A1Methods and dosing regimens comprising a cdk2 inhibitor and a cdk4 inhibitor for treating cancerPFIZER·Filed 2022·Application pending·0 cites
- 3951US2007061898A1Transgenic mouse expressing a polynucleotide encoding human tissue factorYANG JING·Filed 2006·Application pending·0 cites
- 4050US7544466B1Ghrelin o-acyltransferase (GOAT) biochemical assayUNIV TEXAS·Filed 2007·Granted Jun 9, 2009·0 cites·16 claims
- 4150US2021208130A1Assays for cell-based therapies or treatmentsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 4249US8329745B2Small molecule inhibitors of ghrelin O-acyltransferaseHARRAN PATRCIK G·Filed 2011·Granted Dec 11, 2012·0 cites·28 claims
- 4349US2023151116A1Efficacious dose for her2 bispecific antibodyJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 4448US2004157774A1Epitope-tagged recombinant Growth Arrest Specific Gene 6 proteinFiled 2003·Application pending·0 cites
- 4547US2022177587A1Methods and uses of variant cd80 fusion proteins and related constructsALPINE IMMUNE SCIENCES INC·Filed 2019·Application pending·0 cites
- 4646US2016274108A1Diagnostic methods for par4 antagonist therapyBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 4746US2022218785A1Methods and uses of variant icos ligand (icosl) fusion proteinsALPINE IMMUNE SCIENCES INC·Filed 2020·Application pending·0 cites
- 4845US2023118053A1Combination of anti-her2 antibody and cdk inhibitior for tumor treatmentJIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 4943US11753623B2Compositions for treating retinal diseases and methods for making and using themUNIV CALIFORNIA·Filed 2018·Granted Sep 12, 2023·0 cites·14 claims
- 5038US2004005687A1Kinase crystal structuresCANCER RES INST·Filed 2002·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →